Glia Maturation Factor (GMF) Regulates Microglial Expression Phenotypes and the Associated Neurological Deficits in a Mouse Model of Traumatic Brain Injury
Autor: | Govindhasamy Pushpavathi Selvakumar, Duraisamy Kempuraj, Kieran Bazley, Casey Burton, Asgar Zaheer, Sudhanshu P. Raikwar, Smita Zaheer, Shankar S. Iyer, Kristopher Wu, Donald James, Asher Khan, Osaid Khan, Mohammad Ejaz Ahmed, Ramasamy Thangavel |
---|---|
Rok vydání: | 2020 |
Předmět: |
Glia Maturation Factor
0301 basic medicine medicine.medical_specialty Traumatic brain injury Neuroscience (miscellaneous) Motor Activity Glia maturation factor 03 medical and health sciences Cellular and Molecular Neuroscience Cognition 0302 clinical medicine Western blot Downregulation and upregulation Internal medicine Brain Injuries Traumatic medicine Animals Gliosis Phosphorylation Neuroinflammation Mice Knockout Neurons Microglia medicine.diagnostic_test business.industry Macrophages Calcium-Binding Proteins Microfilament Proteins Brain Membrane Proteins medicine.disease Motor coordination Mice Inbred C57BL Cytoskeletal Proteins Disease Models Animal Oxidative Stress Phenotype 030104 developmental biology medicine.anatomical_structure Endocrinology Neurology Cytokines medicine.symptom business Biomarkers 030217 neurology & neurosurgery |
Zdroj: | Molecular Neurobiology. 57:4438-4450 |
ISSN: | 1559-1182 0893-7648 |
DOI: | 10.1007/s12035-020-02040-y |
Popis: | Traumatic brain injury (TBI) induces inflammatory responses through microglial activation and polarization towards a more inflammatory state that contributes to the deleterious secondary brain injury. Glia maturation factor (GMF) is a pro-inflammatory protein that is responsible for neuroinflammation following insult to the brain, such as in TBI. We hypothesized that the absence of GMF in GMF-knockout (GMF-KO) mice would regulate microglial activation state and the M1/M2 phenotypes following TBI. We used the weight drop model of TBI in C57BL/6 mice wild-type (WT) and GMF-KO mice. Immunofluorescence staining, Western blot, and ELISA assays were performed to confirm TBI-induced histopathological and neuroinflammatory changes. Behavioral analysis was done to check motor coordination ability and cognitive function. We demonstrated that the deletion of GMF in GMF-KO mice significantly limited lesion volume, attenuated neuronal loss, inhibited gliosis, and activated microglia adopted predominantly anti-inflammatory (M2) phenotypes. Using an ELISA method, we found a gradual decrease in pro-inflammatory cytokines (TNF-α and IL-6) and upregulation of anti-inflammatory cytokines (IL-4 and IL-10) in GMF-KO mice compared with WT mice, thus, promoting the transition of microglia towards a more predominantly anti-inflammatory (M2) phenotype. GMF-KO mice showed significant improvement in motor ability, memory, and cognition. Overall, our results demonstrate that GMF deficiency regulates microglial polarization, which ameliorates neuronal injury and behavioral impairments following TBI in mice and concludes that GMF is a regulator of neuroinflammation and an ideal therapeutic target for the treatment of TBI. |
Databáze: | OpenAIRE |
Externí odkaz: |